Warning Consulter la version la plus récente.

Information archivée dans le Web

L’information dont il est indiqué qu’elle est archivée est fournie à des fins de référence, de recherche ou de tenue de documents. Elle n’est pas assujettie aux normes Web du gouvernement du Canada et elle n’a pas été modifiée ou mise à jour depuis son archivage. Pour obtenir cette information dans un autre format, veuillez communiquer avec nous.

  1. Government of Canada. The Human Face of Mental Health and Mental Illness in Canada, 2006. Minister of Public Works and Government Services Canada. HP5-19/2006E au catalogue.
  2. Murray CJL, Lopez AD, (rév.). Summary: The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Published by the Harvard School of Public Health on behalf of the World Health Organization and the World Bank, Harvard University Press, 1996.
  3. Organisation mondiale de la santé. The global burden of disease: 2004 update. Switzerland: WHO Press; 2008.
  4. Lim K-L, Jacobs P, Ohinmaa A, Schopflocher D, Dewa CS. A new population-based measure of the economic burden of mental illness in Canada. Chronic Diseases in Canada 2008; 28(3): 92-98.
  5. Organisation mondiale de la santé. Classification internationale des maladies, neuvième revision. Basic Tabulation List with Alphabetical Index. Genève: Organisation mondiale de la santé; 1978.
  6. Organisation mondiale de la santé. Classification statistique internationale des maladies et des problèmes de santé connexes, dixième revison (2e éd.). Genève: Organisation mondiale de la santé; 2004. Disponible en ligne à www.who.int/classifications/icd/en.
  7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1995.
  8. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine. 2006;3(11):e442.
  9. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu H-G, Joyce PR, Karam EG, Lee C-K, Lellouch J, Lepine J-P, Newman SC, Rubio-Stipe M, Wells E, Wickramaratne PJ, Wittchen H-U, Yeh E-K. Cross-National epidemiology of major depression and bipolar disorder. JAMA 1996; 276(4): 293-299.
  10. Beaudet MP. Santé psychologique - la dépression. Rapports sur la santé 1999; 11(3):63-75.
  11. Lepine J-P. Epidemiology, burden, and disability in depression and anxiety. Journal of Clinical Psychiatry 2001; 62(suppl 13):4-10.
  12. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005; 62(6):617-627.
  13. Waraich P, Goldner EM, Somers JM, Hsu L. Prevalence and incidence studies of mood disorders: A systematic review of the literature. Canadian Journal of Psychiatry 2004; 49(2):124-138.
  14. Kessler RC, Berglund P, Demler O, Jin R, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005; 62(6):593-602.
  15. aan het Rot M, Mathew SJ, Charney DS. Neurobiological mechanisms in major depressive disorder. CMAJ 2009; 180(3):305-313.
  16. Lieb R, Isensee B, Höfler M, Pfister H, Wittchen H-U. Parental Major Depression and the Risk of Depression and Other Mental Disorders in Offspring. Arch Gen Psychiatry 2002, 59:365-374.
  17. Sartorius N. The economic and social burden of depression. Journal of Clinical Psychiatry 2001; 62(suppl 15):8-11.
  18. Hansson L. Quality of life in depression and anxiety. International Review of Psychiatry 2002; 14:185-189.
  19. Judd LL, Akiskal HS, Zeller PJ, Paulus M, Leon AC, Maser JD, Endicott J, Coryell W, Kunovac JL, Mueller TI, Rice JP, Keller MB. Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry 2000, 57:375-380.
  20. Waintraub L, Guelfi JD. Nosological validity of dysthymia. Part I: historical, epidemiological and clinical data. Eur Psychiatry 1998; 13:173-180.
  21. Brunello N, Akiskal H, Boyer P, Gessa GL, Howland RH, Langer SZ, Mendlewicz J, Paes de Souza M, Placidi GF, Racagni G, Wessely S. Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas. Journal of Affective Disorders 1999; 52:275-290.
  22. Bagby RM, Ryder AG. Diagnostic discriminability of dysthymia and depressive personality disorder. Depression and Anxiety 1999; 10:41-49.
  23. Oxman T, Barrett JE, Sengupta A, Katon W, Williams JW, Frank E, Hegel M. Status of minor depression or dysthymia in primary care following a randomized controlled treatment. General Hospital Psychiatry 2001; 23:301-310.
  24. Emilien G, Lucia Septien, Brisard C, Corruble E, Bourin M. Bipolar disorder: How far are we from a rigorous definition and effective management? Progress in Neuro-Psychopharmacology & Biological Psychiatry 2007; 31:975-996.
  25. Mental Health America. Bipolar Disorder: What you need to know. Disponible à http://cms.nmha.org/index.cfm?objectid=74F71A5E-1372-4D20-C830054B471F27A0. Consulté en novembre 2010.
  26. Goodwin FK, Jamison KR. Manic-Depressive Illness. Oxford: Oxford University Press; 1990.
  27. Nash J, Potokar J. Anxiety Disorders. Medicine 2004; 32(7):17-21.
  28. Miller MC (rév.). Panic disorder. Harvard Mental Health Letter 2001; 17(9):1-5.
  29. Taylor S, Asmundson GJG, Wald J. Psychopathology of Panic Disorder. Psychiatry 2007; 6(5):188-192.
  30. Vanin JR, Vanin SK. Blocking the cycle of panic disorder. Postgraduate Medicine Online May 1, 1999; 105(5).
  31. Mental Health America. Panic Disorder. Disponible è http://www.mentalhealthamerica.net/go/panic-disorder. Consulté en novembre 2010.
  32. Ettigi P, Meyerhoff A, Chirban J, Jacobs RJ, Wilson RR. The quality of life and employment in panic disorder. J Nerv Ment Dis 1997; 185(6):368-372.
  33. Hackmann A. Agoraphobia: clinical features and treatment strategies. Psychiatry 2007; 6(6):254-257.
  34. Hayward C, Killen D, Taylor CB. The relationship between agoraphobia symptoms and panic disorder in a non-clinical sample of adolescents. Psychological Medicine 2003; 33:733-738.
  35. McCabe L, Cairney J, Veldhuizen S, Herrmann N, Streiner DL. Prevalence and correlates of agoraphobia in older adults. American Journal of Geriatric Psychiatry 2006; 14(6):515-522.
  36. Bienvenu OJ, Onyike CU, Stein MB, Chen, L-S, Samuels J, Nestadt G, Eaton WW. Agoraphobia in adults: incidence and longitudinal relationship with panic. British Journal of Psychiatry 2006; 188:432-438.
  37. Mayo Clinic. Agoraphobia. Disponible à http://www.mayoclinic.com/print/agoraphobia/DS00894/DSection=all&method=print. Consulté en novembre 2010.
  38. Kasper S. Social phobia: The nature of the disorder. Journal of Affective Disorders 1998; 50:S3-S9.
  39. National Institute of Mental Health. Anxiety Disorders.National Institutes of Health 2009. Publication 09 3879. Disponible à http://www.nimh.nih.gov/health/publications/anxiety-disorders/nimhanxiety.pdf. Consulté en novembre 2010.
  40. Wittchen H-U, Fehm L. Epidemiology, patterns of comorbidity, and associated disabilities of social phobia. Psychiatric Clinics of North America 2001; 24(4):617-641.
  41. Miller MC (rév.). Social phobia - Part 1. Harvard Mental Health Letter 1994; 11(4):1-3.
  42. Kessler RC. The impairments caused by social phobia in the general population: Implications for intervention. Acta Psychiatr Scand 2003; 108(Suppl 417):19-27.
  43. Stein MB, Kean YM. Disability and quality of life in social phobia: Epidemiologic findings. Am J Psychiatry 2000; 157:1606-1613.
  44. Wittchen H-U, Fehm L. Epidemiology and natural course of social fears and social phobia. Acta Psychiatr Scand 2003; 108(Suppl 417):4-18.
  45. Tyrer P, Baldwin D. Generalized Anxiety Disorder. Lancet, 2006; 368:2156-2166.
  46. Mayo Clinic. Generalized Anxiety Disorder. Disponible à http://www.mayoclinic.com/health/generalized-anxiety-disorder/DS00502. Consulté en novembre 2010.
  47. National Institute of Mental Health. Generalized Anxiety Disorder. Disponible à http://www.nimh.nih.gov/health/publications/anxiety-disorders/generalized-anxiety-disorder-gad.shtml. Consulté en novembre 2010.
  48. Mental Health America. Generalized Anxiety Disorder (GAD). Disponible à http://www.mentalhealthamerica.net/go/generalized-anxiety-disorder. Consulté en novembre 2010.
  49. Gliatto MF. Generalized anxiety disorder. American Family Physician 2000; 62(7):1591-1600, 1602. Disponible à http://www.aafp.org/afp/20001001/1591.html. Consulté en novembre 2010.
  50. Leon AC, Portera L, Weissman MM. The social costs of anxiety disorders. British Journal of Psychiatry 1995; 166(Suppl 27):19-22.
  51. Cyr NR.Obsessive Compulsive Disorder. AORN Journal 2007; 6(2):277-280.
  52. Keeley ML, Storch EA, Dhungana P, Geffken GR. Pediatric obsessive-compulsive disorder: A guide to assessment and treatment. Issues in Mental Health Nursing 2007; 28:555-574.
  53. Zohar J, Sasson Y, Chopra M, Amiaz R, Nakash N. Obsessive-compulsive disorder. Dans Nutt DJ, Ballenger JC (rev.). Anxiety Disorders. Malden, MA, USA: Blackwell Science Ltd.; 2003. pp. 83-94.
  54. Rasmussen SA, Eisen JL. Clinical features and phenomenology of obsessive compulsive disorder. Psychiatric Annals 1989; 19(2):67-73.
  55. Bobes J, Gonzalez MP, Bascaran MT, Arango C, Saiz PA, Bousono M. Quality of life and disability in patients with obsessive-compulsive disorder. Eur Psychiatry 2001; 16:239-245.
  56. Sasson Y, Zohar J, Chopra M, Lustig M, Iancu J, Hendler T. Epidemiology of obsessive-compulsive disorder: A world view. J Clin Psychiatry 1997; 58(Suppl 12):7-10.
  57. Hollander E. Obsessive-compulsive disorder: The hidden epidemic. J Clin Psychiatry 1997; 58(Suppl 12):3-6.
  58. Rowa K, Antony MM, Swinson RP. Behavioural treatment of obsessive Compulsive Disorder. Behavioural and Cognitive Psychotherapy 2000; 28:353-360.
  59. Nemeroff CB, Bremner JD, Foa EB, Mayberg HS, North CS, Stein MB. Posttraumatic stress disorder: A state-of-the-science review. Journal of psychiatric research 2006; 40:1-21.
  60. Bryant RA. Early predictors of posttraumatic stress disorder. Biol Psychiatry 2003; 53:789-795.
  61. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995; 52(12):1048-1060.
  62. Yehuda R.Risk and resilience in posttraumatic stress disorder. J Clin Psychiatry 2004; 65 (Suppl 1):29-36.
  63. Ozer EJ, Best SR, Lipsey TL, Weiss DS. Predictors of posttraumatic stress disorder and symptoms in adults: A meta-analysis. Psychological Bulletin 2003; 129(1):52-73.
  64. Davidson JRT. Long-term treatment and prevention of posttraumatic stress disorder. J Clin Psychiatry 2004; 65 (Suppl 1):44-48.
  65. Phelan TW. All About Attention Deficit Disorder. Glen Ellyn, Illinois: Child Management Inc., 1993.
  66. Barkley RA. Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment. New York: Guilford Press; 1998.
  67. Rinehart NJ, Bradshaw JL, Brereton AV, Tonge BJ. A clinical and neurobehavioural review of high functioning autism and Asperger's disorder. Australian and New Zealand Journal of Psychiatry 2002; 36:762-770.
  68. Khouzam HR, El-Gabalawi F, Pirwani N, Priest F. Asperger's disorder: A review of its diagnosis and treatment. Comprehensive Psychiatry 2004; 45(3):184-191.
  69. Davids E, Gastpar M. Attention deficit hyperactivity disorder and borderline personality disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2005; 29:865-877.
  70. Kessler RC, Adler LA, Barkley R, Biederman J, Conners CK, Faraone SV, et coll. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: Results from the National Comorbidity Survey replication. Biol Psychiatry 2005; 57(11):1442-1451.
  71. Biederman J. Attention-Deficit/Hyperactivity Disorder: A selective overview. Biol Psychiatry 2005; 57:1215-1220.
  72. Root II RW, Resnik RJ. An update on the diagnosis and treatment of attention-deficit/hepractivity disorder in children. Professional Psychology: Research and Practice 2003; 34(1):34-41.
  73. Pitcher TM, Piek JP, Hay DA. Fine and gross motor ability in males with ADHD. Development Medicine & Child Neurology 2003; 45:525-535.
  74. Blackman GL, Ostrander R, Herman KC. Children with ADHD and depression: A multisource, multimethod assessment of clinical, social, and academic functioning. Journal of Attention Disorders 2005; 8(4):195-207.
  75. Tidmarsh L, Volkmar FR. Diagnosis and epidemiology of autism spectrum disorders. Can J Psychiatry 2003; 48(8):517-525.
  76. Bryson SE, Rogers SJ, Fombonne E. Autism spectrum disorders: Early detection, intervention, education, and psychopharmacological management. Can J Psychiatry 2003; 48(8):506-516.
  77. Bloch-Rosen S pour l'université de Delaware. Research Paper:Asperger's Syndrome, High Functioning Autism, and Disorders of the Autistic Continuum. 1999. Disponible à http://www.aspergersyndrome.com/Paper040899.pdf. Consulté en novembre 2010.
  78. National Institute of Mental Health. Autism Spectrum Disorders (Pervasive Developmental Disorders). National Institutes of Health 2009. Disponible à http://www.nimh.nih.gov/health/publications/autism/nimhautismspectrum.pdf. Consulté en novembre 2010.
  79. Fombonne E. Modern views of autism. Can J Psychiatry 2003; 48(8): 503-505.
  80. Wing L, Potter D. The epidemiology of autistic spectrum disorders: Is the prevalence rising? Mental Retardation and Developmental Disabilities Research Reviews 2002; 8:151-161.
  81. Bailey AJ. The biology of autism. Psychological Medicine 1993; 23:7-11.
  82. Nicolson R, Szatmari P. Genetic and neurodevelopmental influences in autistic disorder. Can J Psychiatry 2003; 48(8):526-537.
  83. Hughes JR. A review of recent reports on autism: 1000 studies published in 2007. Epilepsy & Behavior 2008; 13:425-437.
  84. Maimburg RD, Væth M. Perinatal risk factors and infantile autism. Acta Psychiatr Scand 2006; 114:257-264.
  85. Happé F, Ronald A. The 'Fractionable Autism Triad': A Review of Evidence from Behavioural, Genetic, Cognitive and Neural Research. Neuropsychol Rev 2008; 18:287-304.
  86. Parikh MH, Kolevson A, Hollander E. Psychopharmacology of Aggression in Children and Adolescents with Autism: A Critical Review of Efficacy and Tolerability. Journal of Child and Adolescent Psychopharmacology 2008; 18:157-178.
  87. Ehlers S, Gillberg C. The epidemiology of Asperger Syndrome. A total population study. Journal of Child Psychology and Psychiatry and Allied Disciplines 1993; 34(8):1327-1350.
  88. Mandell DS, Novak MM, Zubritsky CD. Factors associated with age of diagnosis among children with autism spectrum disorders. Pediatrics 2005; 116(6):1480-1486.
  89. Schnur J. Asperger syndrome in children. Journal of the American Academy of Nurse Practitioners 2005; 17(8):302-308.
  90. Rao PA, Beidel DC, Murray MJ. Social Skills Interventions for Children with Asperger's Syndrome or High-Functioning Autism: A Review and Recommendations. J Autism Dev Disord 2008; 38:353-361.
  91. Solomon M, Goodlin-Jones BL, Anders TF. A social adjustment enhancement intervention for high functioning autism, Asperger's syndrome, and pervasive developmental disorder NOS. Journal of Autism and Developmental Disorders 2004; 34(6):649-668.
  92. Beamont R, Sofronoff K. A multi-component social skills intervention for children with Asperger syndrome: The junior detective training program. The Journal of Child Psychology and Psychiatry 2008; 49(7):743-753.
  93. Owens G, Granader Y, Humphrey A, Baron-Cohen S. Lego® therapy and the social use of language programme: An evaluation of two social skills interventions for children with high functioning autism and Asperger syndrome. J Autism Dev Disord 2008; 38:1944-1957.
  94. Toth K, King BH. Asperger's Syndrome: Diagnosis and Treatment. Am J Psychiatry 2008; 168(8):958-963.
  95. Masi G, Mucci M, Millepiedi S. Separation anxiety disorder in children and adolescents: Epidemiology, diagnosis and management. CNS Drugs 2001; 15(2):93-104.
  96. Hanna GL, Fischer DJ, Fluent TE. Separation anxiety disorder and school refusal in children and adolescents. Pediatrics in Review 2006; 27(2):56-63.
  97. Miller MC (rév.). Separation anxiety. Harvard Mental Health Letter 2007; 23(7):1-3.
  98. Shear K, Jin R, Meron Ruscio A, Walters EE, Kessler RC. Prevalence and correlates of estimated DSM-IV child and adult separation anxiety disorder in the National Comorbidiy Survey replication. Am J Psychiatry 2006; 163(3):1074-1083.
  99. Foley DL, Pickles A, Maes HM, Silberg JL, Eaves LJ. Course and short-term outcomes of separation anxiety disorder in a community sample of twins. J Am Acad Child Adolesc Psychiatry 2004; 43(9):1107-1114.
  100. Kearney CA, Sims KE, Pursell CR, Tillotson CA. Separation anxiety disorder in young children: A longitudinal and family analysis. Journal of Child and Adolescent Psychology 2003; 32(4):593-598.
  101. Hoek H., van Hoeken D. Review of prevalence and incidence of eating disorders. Int J Eat Disord 2003;160:248.
  102. Palmer B. Epidemiology, diagnosing and assessing eating disorders. Psychiatry 2008; 7(4):143-146.
  103. Ackard D.M., Fulkerson J.A., Neumark-Sztainer D. Prevalence and Utility of DSM-IV Eating Disorder Diagnostic Criteria among Youth.Int J Eat Disord 2007; 40:409-417.
  104. Bulik CM, Reba L, Siega-Riz A-M, Reichborn-Kjennerud T. Anorexia nervosa: Definition, epidemiology, and cycle of risk. International Journal of Eating Disorders 2005; 37: 52-59.
  105. Chavez M., Insel T.R. Eating Disorders. National Institute of Mental Health's Perspective. American Psychologist 2007, 62(3):159-166.
  106. Hsu GLK. Epidemiology of the eating disorders. Psychiatric Clinics of North America 1996; 19(4):681-697.
  107. Franko DL, Keel PK, Dorer DJ, Blais MA, Delinsky SS, Eddy KT, Charat V, Renn R, Herzog DB. What predicts suicide attempts in women with eating disorders? Psychological Medicine 2004; 34:843-853.
  108. Bulik CM, Sullivan PF, Fear J, Pickering A. Predictors of the development of bulimia nervosa in women with anorexia nervosa. The Journal of Nervous and Mental Disease 1997; 185(11):704-707.
  109. Wonderlich SA, Lilenfeld LR, Riso LP, Engel S, Mitchell JE. Personality and anorexia nervosa. International Journal of Eating Disorders 2005; 37:S68-S71.
  110. Slade R. The Anorexia Nervosa Reference Book. London: Harper & Row; 1984.
  111. Fichter MM, Quadflieg N, Hedlund S. Twelve-year course and outcome predictors of anorexia nervosa. International Journal of Eating Disorders 2006; 39(2):87-100.
  112. Bates T, Zlopasa O, Gasparovic V. Anorexia nervosa: stanje zivotne ugrozenosti. Lijecnicki vjesnik 2007; 129(1-2):11-6.
  113. Carter JC, Blackmore E, Sutandar-Pinnock K, Woodside DB. Relapse in anorexia nervosa: A survival analysis. Psychological Medicine 2004; 34:671-679.
  114. Herzog DB, Dorer DJ, Keel PK, Selwyn SE, Ekeblad ER, Flores AT, Greenwood DN, Burwell RA, Keller MB. Recovery and relapse in anorexia nervosa and bulimia nervosa: a 7.5-year follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry 1999; 38:829-837.
  115. Bulik CM, Sullivan PF, Fear J, Pickering A. Outcome of anorexia nervosa: Eating attitudes, personality, and parental bonding. International Journal of Eating Disorders 2000; 28(2):139-147.
  116. Hay PJ, Bacaltchuk J. Extraires de "Clinical Evidence": Bulimia nervosa. BMJ 2001; 323:33-37. Disponible en ligne à http://bmj.bmjjournals.com/cgi/reprint/323/7303/33.
  117. National Alliance on Mental Illness. Bulimia nervosa. Disponible à http://www.nami.org/Template.cfm?Section=By_Illness&template=/ContentManagement/ContentDisplay.cfm
    &ContentID=65839. Consulté en novembre 2010.
  118. O'Brien KM, Vincent NK. Psychioatric comorbidity in anorexia and bulimia nervosa: nature, prevalence, and causal relationships. Clinical Psychology Review 2003; 23:57-74.
  119. Pearlstein T. Eating disorders and comorbidity. Arch Womens Ment Health 2002; 4:67-68.
  120. Lo Russo L, Campisi G, Di Fede O, Di lIberto C, Panzarella V, Lo Muzio L. Oral manifestations of eating disorders: a critical review. Oral diseases 2008, 14:479-484.
  121. Merck. Mental Retardation/Intellectual Disability. The Merck Manual Home Edition; Section 23: Children's Health Issues; Chapter 285: Mental Retardation/Intellectual Disability [en ligne]. Disponible à http://www.merck.com/mmhe/sec23/ch285/ch285a.html. Consulté en novembre 2010.
  122. Bhasin TK, Brocksen S, Avchen RN, Braun KVN. Prevalence of four developmental disabilities among children aged 8 years - Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1996 and 2000. Dans Surveillance Summaries, 27 janvier 2006. MMWR 2006; 55(SS-1):1-9.
  123. Batshaw ML, Perret YM. Children With Disabilities. U.S.A.: Paul H. Brookes Publishing Company; 1992.
  124. Stephens DL, Collins MD, Dodder RA. A longitudinal study of employment and skill acquisition among individuals with developmental disabilities. Research in Developmental Disabilities 2005; 26:469-486.
  125. Bradley R, Conklin CZ, Westen D. The borderline personality diagnosis in adolescents: Gender differences and subtypes. Journal of Child Psychology and Psychiatry 2005; 46(9):1006-1019.
  126. Ekselius L, Tillfors M, Furmark T, Fredrikson M. Personality disorders in the general population: DSM-IV and ICD-10 defined prevalence as related to sociodemographic profile. Personality and Individual Differences 2001; 30:311-320.
  127. Davidson KM. Cognitive-behavioural therapy for personality disorders. Psychiatry 2008; 7(3): 117-120.
  128. Reichborn-Kjennerud T, Czajkowski N, Neale MC, Ørstavik RE, Torgersen S, Tambs K, Røysamb E, Harris JR, Kendler KS. Genetic and environmental influences on dimensional representations of DSM-IV cluster C personality disorders: a population-based multivariate twin study. Psychological Medicine 2007; 37:645-653.
  129. Skodol AE, Siever LJ, Livesley WJ, Gunderson JG, Pfohl B, Widiger TA. The borderline diagnosis II: Biology, Genetics, and Clinical Course. Biol Psychiatry 2002; 51:951-963.
  130. Huber G. The heterogeneous course of schizophrenia. Schizophrenia Research 1997; 28:177-185.
  131. Gerbaldo H, Georgi K, Pieschl D. The deficit syndrome in first-admission patients with psychotic and non-psychotic disorders. Eur Psychiatry 1997; 12:53-57.
  132. Hafner H, an der Heiden W. Epidemiology of schizophrenia. Canadian Journal of Psychiatry 1997; 42:139-151.
  133. Jablensky A. Epidemiology of schizophrenia: The global burden of disease and disability. Eur Arch Psychiatry Clin Neurosci 2000; 250:274-285.
  134. Maki P, Veijola J, Jones PB, Murray GK, Koponen H, Tienari P, Miettunen J, Tanskanen P, Wahlberg K-E, Koskinen J, Lauronen E, Isohanni M. Predictors of schizophrenia-a review. British Medical Bulletin 2005; 73-74:1-15.
  135. Buskist W, Gerbing DW. Psychology: Boundaries and Frontiers. Glenview, Illinois: Brown Higher Education; 1990.
  136. Siris SG. Suicide and schizophrenia. Journal of Psychopharmacology 2001; 15(2):127-135.
  137. Marwaha S, Johnson S. Schizophrenia and employment: A review. Social Psychiatry and Psychiatric Epidemiology 2004; 39:337-349.
  138. Marwaha S, Johnson S, Bebbington P, Stafford M, Angermeyer MC, Brugha T, Azorin J-M, Kilian R, Hansen K, Toumi M. Rates and correlated of employment in people with schizophrenia in the UK, France, and Germany. British Journal of Psychiatry 2007; 191:30-37.
  139. Rehm J, Taylor B, Room R. Global burden of disease from alcohol, illicit drugs and tobacco. Drug and Alcohol Review 2006; 25:503-13.
  140. Merck. Alcohol. The Merck Manual of Diagnosis and Therapy; Section 15: Psychiatric Disorders; Chapter 198: Drug Use and Dependence [en ligne]. Disponible à http://www.merckmanuals.com/professional/print/sec15/ch198/ch198g.html. Consulté en novembre 2010.
  141. Doweiko HE. Concepts of Chemical Dependency. U.S.A.: Brooks/Cole Publishing Company; 1993.
  142. Grant BF, Stinson FS, Dawson DA, Choi P, Dufour MC, Compton W, Pickering RP, Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 2004; 61(8):807-816.
  143. Hingson RW, Heeren T, Winter MR. Age at drinking onset and alcohol dependence. Arch Pediatr Adolesc Med 2006; 160:739-746.
  144. Hales RE, Yudofsky SC, Talbot JA (rév.) Textbook of Psychiatry. Deuxième édition. Washington, DC: The American Psychiatric Press; 1994.
  145. Becker WC, Fiellin DA, Merrill JO, Schulman B, Finkelstein R, Olsen Y, Busch SH. Opiod use disorders in the United States: Insurance status and treatment access. Drug and Alcohol Dependence 2008; 94:207-213.
  146. Brands B, Spraule B, Marshman J (rév.) Drugs and Drug Abuse. Troisième édition. Toronto: Addiction Research Foundation; 1998.
  147. National Institute on Drug Abuse. Research Report Series: Heroin Abuse and Addiction. NIH Publication 05-4165. 2005. Disponible à http://www.nida.nih.gov/PDF/RRHeroin.pdf. Consulté en novembre 2010.
  148. Merck. Opioids. The Merck Manual of Diagnosis and Therapy; Section 15: Psychiatric Disorders; Chapter 198: Drug Use and Dependence [en ligne]. Disponible à http://www.merckmanuals.com/professional/sec15/ch198/ch198f.html. Consulté en novembre 2010.
  149. Merck. Marijuana (Cannabis). The Merck Manual of Diagnosis and Therapy; Section 15: Psychiatric Disorders; Chapter 198: Drug Use and Dependence [en ligne]. Disponible à http://www.merckmanuals.com/professional/print/sec15/ch198/ch198i.html. Consulté en novembre 2010.
  150. Barnes GE, Barnes MD, Patton D. Prevalence and predictors of "heavy" marijuana use in a Canadian youth sample. Substance Use and Misuse 2005; 40:1849-1863.
  151. Kalont H, Corrigal W. The Health Effects of Cannabis. Canada: Center for Addiction and Mental Health; 1999.
Date de modification :